Free Trial
NYSE:STVN

Stevanato Group (STVN) Stock Price, News & Analysis

Stevanato Group logo
€19.50 +0.24 (+1.24%)
As of 09:39 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Stevanato Group Stock (NYSE:STVN)

Advanced

Key Stats

Today's Range
€18.82
▼
€19.48
50-Day Range
€19.20
▼
€22.70
52-Week Range
€12.89
▼
€27.99
Volume
398,400 shs
Average Volume
501,411 shs
Market Capitalization
€5.90 billion
P/E Ratio
34.28
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill. Stevanato Group also supplies drug-delivery systems, including components and devices for injectable therapies, along with inspection machines, assembly and packaging equipment, and related engineering and analytical services.

Founded in 1949 by Giovanni Stevanato, the company has expanded from its Italian origins into an international organization serving pharmaceutical and biotechnology customers in Europe, North America, Asia and other global markets. Stevanato Group is headquartered in Piombino Dese, Italy, and has been led by Executive Chairman Franco Stevanato, a member of the founding family.

AI Generated. May Contain Errors.

Stevanato Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
67th Percentile Overall Score

STVN MarketRank™: 
3.368948687505 of 5 stars

Stevanato Group scored higher than 67% of companies evaluated by MarketBeat, and ranked 260th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Stevanato Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 2 strong buy ratings, 2 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Stevanato Group has only been the subject of 3 research reports in the past 90 days.

  • Read more about Stevanato Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Stevanato Group are expected to grow by 17.39% in the coming year, from €0.69 to €0.81 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Stevanato Group is 34.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 35.82.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Stevanato Group is 34.28, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 202.90.

  • Price to Earnings Growth Ratio

    Stevanato Group has a PEG Ratio of 1.57. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Stevanato Group has a P/B Ratio of 3.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.36% of the float of Stevanato Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Stevanato Group has a short interest ratio ("days to cover") of 3.47, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Stevanato Group has recently decreased by 8.01%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Stevanato Group does not currently pay a dividend.

  • Dividend Growth

    Stevanato Group has only been increasing its dividend for 1 years.

  • Dividend Sustainability

    Based on earnings estimates, Stevanato Group will have a dividend payout ratio of 7.41% next year. This indicates that Stevanato Group will be able to sustain or increase its dividend.

  • News Sentiment

    Stevanato Group has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Stevanato Group this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Stevanato Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought €0.00 in company stock and sold €459,738.00 in company stock.

  • Percentage Held by Institutions

    Stevanato Group has minimal institutional ownership at this time.

  • Read more about Stevanato Group's insider trading history.
Receive STVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stevanato Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

STVN Stock News Headlines

A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
Morgan Stanley Gives a Hold Rating to Stevanato Group (STVN)
Stevanato Group (NYSE:STVN) Stock Falls 6.2% on Insider Selling
See More Headlines

STVN Stock Analysis - Frequently Asked Questions

Stevanato Group's stock was trading at €20.11 on January 1st, 2026. Since then, STVN shares have decreased by 4.5% and is now trading at €19.20.

Stevanato Group S.p.A. (NYSE:STVN) posted its quarterly earnings results on Wednesday, August, 5th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by $0.01. The firm earned $302 million during the quarter. Stevanato Group had a net margin of 10.99% and a trailing twelve-month return on equity of 10.43%.
Read the conference call transcript
.

Stevanato Group (STVN) raised $720 million in an initial public offering on Friday, July 16th 2021. The company issued 32,000,000 shares at $21.00-$24.00 per share.

Top institutional shareholders of Stevanato Group include Fenimore Asset Management Inc (0.19%), Cooper Investors PTY Ltd. (0.17%) and Confluence Investment Management LLC (0.10%). Insiders that own company stock include Mauro Stocchi, Lago Marco Dal, Madhavan Balachandran, Donald E Morel Jr, William J Federici, Karen Flynn, Luciano Santel and Elisabetta Magistretti.
View institutional ownership trends
.

Shares of STVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stevanato Group investors own include LKQ (LKQ), BNY Mellon Municipal Bond Infrastructure Fund (DMB), Eaton (ETN), AAK AB (publ.) (ARHUF), AdvanSix (ASIX), Best Buy (BBY) and Analog Devices (ADI).

Company Calendar

Record date for 7/29 Dividend
6/11/2026
Ex-Dividend for 7/29 Dividend
6/11/2026
Dividend Payable
7/29/2026
Last Earnings
8/05/2026
Today
10/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:STVN
CIK
1849853
Fax
N/A
Employees
6,010
Year Founded
1949

Profitability

EPS (Trailing Twelve Months)
€0.56
Trailing P/E Ratio
34.28
Forward P/E Ratio
28.26
P/E Growth
1.57
Net Income
€158.21 million
Net Margins
10.99%
Pretax Margin
15.59%
Return on Equity
10.43%
Return on Assets
6.16%

Debt

Debt-to-Equity Ratio
0.21
Current Ratio
1.61
Quick Ratio
1.08

Sales & Book Value

Annual Sales
€1.34 billion
Price / Sales
4.40
Cash Flow
€0.89 per share
Price / Cash Flow
21.81
Book Value
€5.55 per share
Price / Book
3.51

Miscellaneous

Outstanding Shares
302,840,000
Free Float
N/A
Market Cap
€5.90 billion
Optionable
Optionable
Beta
0.78

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NYSE:STVN) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners